1-1 of 1
Richard A. Brigandi
Close
Sort by
Journal Articles

The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma

Clinical Trials & Observations
Andrew Spencer, Sung-Soo Yoon, Simon J. Harrison, Shannon R. Morris, Deborah A. Smith, Richard A. Brigandi, Jennifer Gauvin, Rakesh Kumar, Joanna B. Opalinska, Christine Chen
Journal: Blood
Blood (2014) 124 (14): 2190–2195.
https://doi.org/10.1182/blood-2014-03-559963
Published: 2014
Includes: Supplemental data